421 related articles for article (PubMed ID: 29579402)
1. Biodegradable Polymeric Nanoparticles for Therapeutic Cancer Treatments.
Karlsson J; Vaughan HJ; Green JJ
Annu Rev Chem Biomol Eng; 2018 Jun; 9():105-127. PubMed ID: 29579402
[TBL] [Abstract][Full Text] [Related]
2. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
3. Polymeric nanoparticles as carrier for targeted and controlled delivery of anticancer agents.
Taghipour-Sabzevar V; Sharifi T; Moghaddam MM
Ther Deliv; 2019 Aug; 10(8):527-550. PubMed ID: 31496433
[TBL] [Abstract][Full Text] [Related]
4. Stimuli-responsive Polymeric Nanosystems for Therapeutic Applications.
Handa M; Singh A; Flora SJS; Shukla R
Curr Pharm Des; 2022; 28(11):910-921. PubMed ID: 34879797
[TBL] [Abstract][Full Text] [Related]
5. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
Ge Z; Liu S
Chem Soc Rev; 2013 Sep; 42(17):7289-325. PubMed ID: 23549663
[TBL] [Abstract][Full Text] [Related]
6. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Targeted Nanomedicine for Immunotherapy.
Cabral H; Kinoh H; Kataoka K
Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
[TBL] [Abstract][Full Text] [Related]
8. Polymer-mediated nanoformulations: a promising strategy for cancer immunotherapy.
Kaur S; Saini AK; Tuli HS; Garg N; Joshi H; Varol M; Kaur J; Chhillar AK; Saini RV
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1311-1326. PubMed ID: 37695334
[TBL] [Abstract][Full Text] [Related]
9. Drug Delivery Systems Based on Polymeric Micelles and Ultrasound: A Review.
Tanbour R; Martins AM; Pitt WG; Husseini GA
Curr Pharm Des; 2016; 22(19):2796-807. PubMed ID: 26898742
[TBL] [Abstract][Full Text] [Related]
10. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
11. Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer.
Rajabi M; Adeyeye M; Mousa SA
Curr Med Chem; 2019; 26(30):5664-5683. PubMed ID: 31250748
[TBL] [Abstract][Full Text] [Related]
12. Engineered strategies to enhance tumor penetration of drug-loaded nanoparticles.
Souri M; Soltani M; Moradi Kashkooli F; Kiani Shahvandi M
J Control Release; 2022 Jan; 341():227-246. PubMed ID: 34822909
[TBL] [Abstract][Full Text] [Related]
13. Tumor Targeted Nanocarriers for Immunotherapy.
Baeza A
Molecules; 2020 Mar; 25(7):. PubMed ID: 32225049
[TBL] [Abstract][Full Text] [Related]
14. Biopolymers for Antitumor Implantable Drug Delivery Systems: Recent Advances and Future Outlook.
Talebian S; Foroughi J; Wade SJ; Vine KL; Dolatshahi-Pirouz A; Mehrali M; Conde J; Wallace GG
Adv Mater; 2018 Aug; 30(31):e1706665. PubMed ID: 29756237
[TBL] [Abstract][Full Text] [Related]
15. Light-Activated Hypoxia-Responsive Nanocarriers for Enhanced Anticancer Therapy.
Qian C; Yu J; Chen Y; Hu Q; Xiao X; Sun W; Wang C; Feng P; Shen QD; Gu Z
Adv Mater; 2016 May; 28(17):3313-20. PubMed ID: 26948067
[TBL] [Abstract][Full Text] [Related]
16. DePEGylation strategies to increase cancer nanomedicine efficacy.
Kong L; Campbell F; Kros A
Nanoscale Horiz; 2019 Mar; 4(2):378-387. PubMed ID: 32254090
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrin-based Polymeric Nanoparticles as Efficient Carriers for Anticancer Drugs.
Duchene D; Cavalli R; Gref R
Curr Pharm Biotechnol; 2016; 17(3):248-55. PubMed ID: 26517333
[TBL] [Abstract][Full Text] [Related]
18. Direct Nucleus-Targeted Drug Delivery Using Cascade pH
Cao Z; Li D; Wang J; Xiong M; Yang X
Small; 2019 Sep; 15(36):e1902022. PubMed ID: 31318147
[TBL] [Abstract][Full Text] [Related]
19. Preparation Method and In Vitro Characterization of Nanoparticles Sensitive to Tumor Microenvironment.
Blal N; Guarnieri D
Methods Mol Biol; 2024; 2748():85-98. PubMed ID: 38070109
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicines for advanced cancer treatments: Transitioning towards responsive systems.
van Elk M; Murphy BP; Eufrásio-da-Silva T; O'Reilly DP; Vermonden T; Hennink WE; Duffy GP; Ruiz-Hernández E
Int J Pharm; 2016 Dec; 515(1-2):132-164. PubMed ID: 27725268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
